San Francisco, California, March 23, 2021—Wave 80 Biosciences today announced a major expansion of its IP portfolio with the issuance of U.S. Patent 10,955,067, Methods and Systems for Enhanced [...]
Promising results are being seen in the performance of new sample preparation modules being developed for respiratory infection, Wave 80 announced today. The significant challenges associated [...]
Positioning to meet emerging needs in respiratory infection, STIs, and other high unmet need areas, Wave 80 announced further improvements in the development of its high-performance sample prep [...]
As an invited keynote speaker at today’s MedInnovations meeting, Wave 80’s Dan Laser described the role for key emerging technologies in the life sciences. In a subsequent panel [...]
Grant by United States Patent and Trademark Office covers groundbreaking Wave 80 technology for high-performance molecular assays, liquid biopsy, and other applications.
As part of the occasional Amgen Innovator Series featuring high-profile Bay Area life sciences leaders, Wave 80 founder Dan Laser spoke today at the California Institute for Quantitative [...]
On World Tuberculosis Day, Wave 80 announced the latest advances in its programs seeking to contribute to global efforts in a disease that persists as a major threat to human health around the [...]
Washington, DC, April 6, 2016—At a major gathering of leaders in the tuberculosis field, held in Washington DC, Wave 80 founder and Board of Directors chairman Dr. Daniel Laser was joined by Palu [...]
Liquid micropiston-based sample prep technology meet emerging needs around sequencing multi-drug resistant strains
Strong NGO support cited for system's capacity for multiplexing and exceptionally high performance sample prep module
